"Receptors, Androgen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA.
| Descriptor ID |
D011944
|
| MeSH Number(s) |
D12.776.826.750.150
|
| Concept/Terms |
Receptors, Androgen- Receptors, Androgen
- Androgen Receptor
- Receptor, Androgen
- Androgen Receptors
- Dihydrotestosterone Receptors
- Testosterone Receptor
- Receptors, Androgens
- Androgens Receptors
- Receptors, Dihydrotestosterone
- Receptors, Stanolone
- Stanolone Receptors
- Stanolone Receptor
- Receptor, Stanolone
- 5 alpha-Dihydrotestosterone Receptor
- 5 alpha Dihydrotestosterone Receptor
- Receptor, 5 alpha-Dihydrotestosterone
- alpha-Dihydrotestosterone Receptor, 5
- Receptor, Testosterone
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Androgen".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Androgen".
This graph shows the total number of publications written about "Receptors, Androgen" by people in this website by year, and whether "Receptors, Androgen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 |
| 1996 | 1 | 1 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 3 | 1 | 4 |
| 2000 | 3 | 0 | 3 |
| 2001 | 4 | 1 | 5 |
| 2002 | 2 | 0 | 2 |
| 2003 | 9 | 1 | 10 |
| 2004 | 5 | 4 | 9 |
| 2005 | 4 | 3 | 7 |
| 2006 | 3 | 2 | 5 |
| 2007 | 4 | 6 | 10 |
| 2008 | 5 | 1 | 6 |
| 2009 | 5 | 3 | 8 |
| 2010 | 0 | 5 | 5 |
| 2011 | 7 | 3 | 10 |
| 2012 | 5 | 2 | 7 |
| 2013 | 7 | 4 | 11 |
| 2014 | 9 | 4 | 13 |
| 2015 | 8 | 2 | 10 |
| 2016 | 8 | 5 | 13 |
| 2017 | 3 | 3 | 6 |
| 2018 | 7 | 3 | 10 |
| 2019 | 4 | 2 | 6 |
| 2020 | 9 | 2 | 11 |
| 2021 | 6 | 2 | 8 |
| 2022 | 6 | 4 | 10 |
| 2023 | 2 | 5 | 7 |
| 2024 | 5 | 2 | 7 |
| 2025 | 3 | 2 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Androgen" by people in Profiles.
-
Real-world trends in the use and outcomes of novel androgen receptor signaling inhibitor therapy in patients with non-metastatic castration-resistant prostate cancer: a multicenter retrospective study. Int J Clin Oncol. 2025 Sep; 30(9):1858-1865.
-
Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor-Positive Triple-Negative Breast Cancer by Inhibiting c-MYC-mediated Tumorigenesis. Mol Cancer Ther. 2025 Jun 04; 24(6):870-883.
-
Real-world effectiveness of darolutamide in metastatic castration-resistant prostate cancer. Endocr Relat Cancer. 2025 Jun 01; 32(6).
-
Paving the path ForwARd: Advances and challenges in androgen receptor targeting in breast cancer. Cancer Treat Rev. 2025 Jul; 138:102958.
-
Androgen receptor ubiquitination links KCTD13 to genitourinary tract defects. FASEB J. 2025 Feb 28; 39(4):e70406.
-
Role of Kctd13 in modulating AR and SOX9 expression in different penile cell populations. Andrology. 2025 Jul; 13(5):1201-1212.
-
Castration-resistant prostate cancer is resensitized to androgen deprivation by autophagy-dependent apoptosis induced by blocking SKP2. Sci Signal. 2024 12 17; 17(867):eadk4122.
-
Testosterone acts through the membrane protein GPRC6A to cause cardiac edema in zebrafish embryos. Development. 2024 Dec 01; 151(23).
-
Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable Therapies. Clin Cancer Res. 2024 Oct 15; 30(20):4768-4779.
-
A molecular switch from tumor suppressor to oncogene in ER+ve breast cancer: Role of androgen receptor, JAK-STAT, and lineage plasticity. Proc Natl Acad Sci U S A. 2024 Oct; 121(40):e2406837121.